Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules
about
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel DiseasesAmelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1.A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway.Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis.Non-alcoholic fatty liver disease, diet and gut microbiota.Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum.A Novel Role for Programmed Cell Death Receptor Ligand-1 (PD-L1) in Sepsis-Induced Intestinal Dysfunction.Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.A Probiotic Preparation Duolac-Gold Ameliorates Dextran Sulphate Sodium-induced Mouse Colitis by Downregulating the Expression of IL-6.Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice.Local and systemic Th17 immune response associated with advanced stage colon cancer.Simultaneous Amelioratation of Colitis and Liver Injury in Mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27.Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models
P2860
Q26784194-B37EB66D-CD8F-4458-84A3-5A2E40610FB7Q33908943-FE939148-A144-46BD-849B-333631EFF9D1Q35048916-D96A98DE-F628-4714-A35F-C597952166DCQ35564093-501B8F7B-38F9-445F-A91B-02DD74605868Q35728214-50BB08A1-FE6A-455E-9C1E-F9838D78FF09Q35746602-B955C8B7-6165-42A8-A7D7-7C94821CA90EQ37604045-EF8452DE-A89F-4420-BBD5-438885A88132Q37662501-AB24E2AC-13A1-421F-AD27-4C0731FCA3C8Q38794312-040321ED-C76D-4253-873C-F21A50C0063BQ39135689-FFA3F499-6703-4947-8BDD-09E8FDA77CA6Q41647419-26CA2D11-408B-40FF-ABD5-2A12DEF272A1Q51250611-B79EC863-DCE4-4FA1-96C2-BCE24FAB8EDBQ54408784-0025FD02-AC2D-4E6C-BF28-AD9CE852C008Q57115983-DFC8D8E4-DB9E-43DD-ADDE-D5932F06052A
P2860
Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Bifidobacterium longum allevia ...... helial costimulatory molecules
@en
type
label
Bifidobacterium longum allevia ...... helial costimulatory molecules
@en
prefLabel
Bifidobacterium longum allevia ...... helial costimulatory molecules
@en
P2093
P2860
P1433
P1476
Bifidobacterium longum allevia ...... helial costimulatory molecules
@en
P2093
Eiji Miyauchi
Hidetoshi Morita
Junki Miyamoto
Seiji Kawamoto
Soichi Tanabe
Tasuku Ogita
P2860
P304
P356
10.1371/JOURNAL.PONE.0079735
P407
P577
2013-11-08T00:00:00Z